Breaking News

You are here » Indian-Commodity  :  Commodities  :  Gold, Silver & Bullion  :  Gold futures end higher on Friday

27-Aug2016

Gold futures end higher on Friday

Gold futures ended higher on Friday as the dollar dipped following a slight downward revision to US second quarter economic growth, but investors remained wary after a speech by Federal Reserve head Janet Yellen indicated that an increase in interest rates may be coming soon.

Gold futures for December delivery gained $1.30 or 0.1 percent to settle at $1,325.90 an ounce on the Comex division of the New York Mercantile Exchange. While, spot gold was up 0.02 percent to $1,321.52 an ounce.

 


Related News

View all news

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures end higher on Thursday

Gold futures ended higher on Thursday despite rising US dollar on minutes of the Federal Reserve's latest policy meeting indicating that the central bank is staying the course on interest rate hikes.Gold......

Gold futures decline on firming dollar

Gold futures declined on MCX as traders await the minutes from the US Federal Reserve's latest policy meeting for fresh clues on the pace of interest rate hikes. Besides, a firming dollar against some......

Top News

View all news

Reliance Power's arm wins arbitration award against NACC

Reliance Power's Wholly Owned Subsidiary -- Sasan Power has won an arbitration award against North American Coal Corporation (NACC). This is a major milestone in this arbitration with the award received......

Tata Steel's arm signs agreement to divest entire stake in Black Ginger 461

Tata Steel's wholly owned indirect subsidiary -- TS Global Minerals Holdings Pte has entered into an agreement to divest its entire stake in its wholly owned step down subsidiary Black Ginger 461 Pty which......

Biocon, Mylan N.V. receive positive approval for Ogivri

Biocon and Mylan N.V. have been issued a positive opinion recommending approval of Ogivri, a biosimilar to Roche's Herceptin (trastuzumab) by the European Medicines Agency's Committee for Medicinal Products......